Literature DB >> 15968564

[Skin and soft tissue infections. Surgical procedures for necrotizing soft tissue infections].

C Schinkel1.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15968564     DOI: 10.1007/s00113-005-0959-3

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


× No keyword cloud information.
  9 in total

1.  [Basic principles of infected bone and soft tissue surgery].

Authors:  W Lungershausen
Journal:  Zentralbl Chir       Date:  2001-01       Impact factor: 0.942

Review 2.  Source control in the management of severe sepsis and septic shock: an evidence-based review.

Authors:  John C Marshall; Ronald V Maier; Maria Jimenez; E Patchen Dellinger
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

Review 3.  [Primary soft tissue treatment and soft tissue reconstruction].

Authors:  W Knopp; H U Steinau
Journal:  Chirurg       Date:  1991-05       Impact factor: 0.955

4.  Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study.

Authors:  B D Bilton; G B Zibari; R W McMillan; D F Aultman; G Dunn; J C McDonald
Journal:  Am Surg       Date:  1998-05       Impact factor: 0.688

5.  [Treatment of severe soft tissue infection].

Authors:  H Kuderna
Journal:  Chirurg       Date:  1987-11       Impact factor: 0.955

Review 6.  Soft tissue infections.

Authors:  R T Lewis
Journal:  World J Surg       Date:  1998-02       Impact factor: 3.352

Review 7.  A practical guide to the treatment of complicated skin and soft tissue infections.

Authors:  Horatio B Fung; Joanne Y Chang; Stephen Kuczynski
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  Necrotizing fasciitis.

Authors:  R J Green; D C Dafoe; T A Raffin
Journal:  Chest       Date:  1996-07       Impact factor: 9.410

9.  Determinants of mortality for necrotizing soft-tissue infections.

Authors:  C R McHenry; J J Piotrowski; D Petrinic; M A Malangoni
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.